{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T03:51:15Z","timestamp":1772941875563,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"am","delay-in-days":353,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016853","name":"Lysosomal Disease Network","doi-asserted-by":"publisher","award":["U54NS065768"],"award-info":[{"award-number":["U54NS065768"]}],"id":[{"id":"10.13039\/100016853","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016650","name":"Rare Diseases Clinical Research Network","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016650","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ymgme.2025.109222","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T15:58:32Z","timestamp":1755100712000},"page":"109222","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fabry disease and evolving story of I198T and A143T: Variants of varying clinical consequence (VVCC)"],"prefix":"10.1016","volume":"146","author":[{"given":"Nishitha R.","family":"Pillai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofia","family":"Shrestha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alia","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace Bronken","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chester B.","family":"Whitley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeanine","family":"Jarnes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2025.109222_bb0005","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.ymgme.2018.02.014","article-title":"Fabry disease revisited: management and treatment recommendations for adult patients","volume":"123","author":"Ortiz","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2025.109222_bb0010","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1681\/ASN.2016090964","article-title":"Characterization of classical and nonclassical Fabry disease: a multicenter study","volume":"28","author":"Arends","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ymgme.2025.109222_bb0015","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1750-1172-5-30","article-title":"Fabry disease","volume":"5","author":"Germain","year":"2010","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2025.109222_bb0020","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2023-002251","article-title":"Late-onset and classic phenotypes of Fabry disease in males with the GLA-Thr410Ala mutation","volume":"10","author":"Valtola","year":"2023","journal-title":"Open Heart"},{"key":"10.1016\/j.ymgme.2025.109222_bb0025","doi-asserted-by":"crossref","first-page":"D1062","DOI":"10.1093\/nar\/gkx1153","article-title":"ClinVar: improving access to variant interpretations and supporting evidence","volume":"46","author":"Landrum","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymgme.2025.109222_bb0030","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.jcf.2020.03.019","article-title":"Penetrance is a critical parameter for assessing the disease liability of CFTR variants","volume":"19","author":"Boussaroque","year":"2020","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.ymgme.2025.109222_bb0035","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/s41436-020-0822-5","article-title":"CFTR variant testing: a technical standard of the American College of Medical Genetics and Genomics (ACMG)","volume":"22","author":"Deignan","year":"2020","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2025.109222_bb0040","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1002\/ppul.26323","article-title":"Clinical outcome of individuals carrying 5T;TG12 in trans with CFTR variants with varying clinical consequences","volume":"58","author":"Tosco","year":"2023","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.ymgme.2025.109222_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/biom13101521","article-title":"Functional consequences of pathogenic variants of the GJB2 gene (Cx26) localized in different Cx26 domains","volume":"13","author":"Posukh","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.ymgme.2025.109222_bb0050","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/00125817-200207000-00004","article-title":"GJB2 (connexin 26) variants and nonsyndromic sensorineural hearing loss: a HuGE review","volume":"4","author":"Kenneson","year":"2002","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2025.109222_bb0055","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1136\/jmg-2022-108523","article-title":"Prevalence of Fabry disease-causing variants in the UK biobank","volume":"60","author":"Gilchrist","year":"2023","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.ymgme.2025.109222_bb0060","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cca.2018.02.021","article-title":"Functional and pharmacological evaluation of novel GLA variants in Fabry disease identifies six (two de novo) causative mutations and two amenable variants to the chaperone DGJ","volume":"481","author":"Ferri","year":"2018","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ymgme.2025.109222_bb0065","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/ejhg.2011.87","article-title":"Fabry or not Fabry--a question of ascertainment","volume":"19","author":"Houge","year":"2011","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2025.109222_bb0070","first-page":"303","article-title":"Fabry disease in donor kidneys with 3- and 12-year follow-up after transplantation","volume":"3","author":"Aaseb\u00f8","year":"2010","journal-title":"NDT Plus"},{"key":"10.1016\/j.ymgme.2025.109222_bb0075","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s10545-014-9799-z","article-title":"Raynaud's phenomenon associated with Fabry disease","volume":"38","author":"Germain","year":"2015","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2025.109222_bb0080","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/cge.12613","article-title":"X-chromosome inactivation in female patients with Fabry disease","volume":"89","author":"Echevarria","year":"2016","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ymgme.2025.109222_bb0085","first-page":"101","article-title":"questioning the pathogenic role of the GLA p.Ala143Thr \"mutation\" in Fabry disease: implications for Screening Studies and ERT","volume":"8","author":"Terryn","year":"2013","journal-title":"JIMD Rep."},{"key":"10.1016\/j.ymgme.2025.109222_bb0090","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/cge.12449","article-title":"Diagnostic dilemmas in Fabry disease: a case series study on GLA mutations of unknown clinical significance","volume":"88","author":"Smid","year":"2015","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ymgme.2025.109222_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics10121027","article-title":"Assessment of peripheral nervous system alterations in patients with the Fabry related GLA-variant p.A143T","volume":"10","author":"Godel","year":"2020","journal-title":"Diagnostics"},{"key":"10.1016\/j.ymgme.2025.109222_bb0100","doi-asserted-by":"crossref","DOI":"10.1186\/s42358-019-0111-7","article-title":"Higher rate of rheumatic manifestations and delay in diagnosis in Brazilian Fabry disease patients","volume":"60","author":"Rosa Neto","year":"2020","journal-title":"Adv. Rheumatol."},{"key":"10.1016\/j.ymgme.2025.109222_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2018.00336","article-title":"Galactosidase alpha p.A143T variant Fabry disease may result in a phenotype with multifocal microvascular cerebral involvement at a young age","volume":"9","author":"Hauth","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.ymgme.2025.109222_bb0110","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1001\/archneur.63.3.453","article-title":"Later-onset Fabry disease: an adult variant presenting with the cramp-fasciculation syndrome","volume":"63","author":"Nance","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ymgme.2025.109222_bb0115","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1161\/STROKEAHA.109.558320","article-title":"Frequency of unrecognized Fabry disease among young European-American and African-American men with first ischemic stroke","volume":"41","author":"Wozniak","year":"2010","journal-title":"Stroke"},{"key":"10.1016\/j.ymgme.2025.109222_bb0120","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1136\/jmedgenet-2019-106467","article-title":"Use of a rare disease registry for establishing phenotypic classification of previously unassigned GLA variants: a consensus classification system by a multispecialty Fabry disease genotype-phenotype workgroup","volume":"57","author":"Germain","year":"2020","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.ymgme.2025.109222_bb0125","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jpeds.2017.06.048","article-title":"Newborn screening for lysosomal storage disorders in Illinois: the initial 15-month experience","volume":"190","author":"Burton","year":"2017","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2025.109222_bb0130","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/ajmg.c.31998","article-title":"Newborn screening for Fabry disease in Oregon: approaching the iceberg of A143T and variants of uncertain significance","volume":"190","author":"Viall","year":"2022","journal-title":"Am. J. Med. Genet. C: Semin. Med. Genet."},{"key":"10.1016\/j.ymgme.2025.109222_bb0135","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jpeds.2014.09.023","article-title":"Lysosomal storage disorder screening implementation: findings from the first six months of full population pilot testing in Missouri","volume":"166","author":"Hopkins","year":"2015","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2025.109222_bb0140","doi-asserted-by":"crossref","DOI":"10.1159\/000543920","article-title":"Further clinical and biochemical phenotype of GLA p.A143T: a Fabry disease newborn screening experience","author":"Paltzer","year":"2025","journal-title":"Nephron"},{"key":"10.1016\/j.ymgme.2025.109222_bb0145","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1136\/heartjnl-2019-315933","article-title":"Cardiomyopathy associated with the Ala143Thr variant of the \u03b1-galactosidase A gene","volume":"106","author":"Valtola","year":"2020","journal-title":"Heart"},{"key":"10.1016\/j.ymgme.2025.109222_bb0150","doi-asserted-by":"crossref","first-page":"361","DOI":"10.21037\/cdt.2019.06.02","article-title":"Cardiovascular magnetic resonance imaging for structural heart disease","volume":"10","author":"Situ","year":"2020","journal-title":"Cardiovasc. Diagn. Ther."},{"key":"10.1016\/j.ymgme.2025.109222_bb0155","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ymgme.2019.03.010","article-title":"Low-dose agalsidase beta treatment in male pediatric patients with Fabry disease: a 5-year randomized controlled trial","volume":"127","author":"Ramaswami","year":"2019","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2025.109222_bb0160","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3109\/03009740903270631","article-title":"Bone and joint involvement in Fabry disease","volume":"39","author":"Sacre","year":"2010","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.ymgme.2025.109222_bb0165","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1302\/0301-620X.98B9.37038","article-title":"The Charcot foot: pathophysiology, diagnosis and classification","volume":"98-b","author":"Trieb","year":"2016","journal-title":"Bone Joint J."},{"key":"10.1016\/j.ymgme.2025.109222_bb0170","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1002\/art.27547","article-title":"Ligament and bone pathologic abnormalities more frequent in neuropathic joint disease in comparison with degenerative arthritis of the foot and ankle: implications for understanding rapidly progressive joint degeneration","volume":"62","author":"Halstead","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ymgme.2025.109222_bb0175","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1024\/0301-1526\/a000017","article-title":"Fabry disease - vascular manifestations","volume":"39","author":"Karetova","year":"2010","journal-title":"Vasa"}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719225002136?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719225002136?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T11:22:13Z","timestamp":1772882533000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719225002136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":35,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S1096719225002136"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2025.109222","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fabry disease and evolving story of I198T and A143T: Variants of varying clinical consequence (VVCC)","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2025.109222","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109222"}}